home / stock / ci / ci articles

CI Articles, Cigna Corporation

Stock Information
Company Name: Cigna Corporation
Stock Symbol: CI
Market: NYSE
Website: cigna.com
Menu
CI CI Quote CI Short CI News CI Articles CI Message Board
Get CI Alerts

News, Short Squeeze, Breakout and More Instantly...
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations | Benzinga

Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the&n...
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US | Benzinga

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to ma...

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises | Benzinga

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down ...

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,400 Today | Benzinga

Cigna Group (NYSE:CI) has outperformed the market over the past 15 years by 6.22% on an annualized basis producing an average annual return of 18.8...
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth | Benzinga

The U.S. Federal Trade Commission (FTC) has highlighted significant concerns regarding consolidating pharmacies and health insurance companies, foc...

Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says | Benzinga

Piper Sandler has initiated coverage on Cigna Corporation (NYSE:CI), a diversified managed care and healthcare delivery organization specializing i...

Here's How Much $1000 Invested In Cigna Group 5 Years Ago Would Be Worth Today | Benzinga

Cigna Group (NYSE:CI) has outperformed the market over the past 5 years by 2.89% on an annualized basis producing an average annual return of 16.26...
Compelling Reasons to Hold on to Cigna Stock for Now | Benzinga

The Cigna Group (NYSE: CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance ...

AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability | Benzinga

AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-pric...

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,700 Today | Benzinga

Cigna Group (NYSE:CI) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 13.92...
Next 10